FluorouracilOrganoplatinum CompoundsLeucovorinAntineoplastic Combined Chemotherapy ProtocolsColorectal NeoplasmsAntimetabolites, AntineoplasticCamptothecinDeoxycytidineDrug Administration ScheduleInfusions, IntravenousAntineoplastic AgentsDihydrouracil Dehydrogenase (NADP)AdenocarcinomaCisplatinTreatment OutcomeColonic NeoplasmsChemotherapy, AdjuvantThymidylate SynthaseDisease-Free SurvivalNeoplasm MetastasisChronotherapySurvival AnalysisRectal NeoplasmsUracilCombined Modality TherapyStomach NeoplasmsFloxuridineTegafurDrug Resistance, NeoplasmEpirubicinMaximum Tolerated DoseSurvival RateMethotrexateLiver NeoplasmsDose-Response Relationship, DrugNeurotoxicity SyndromesNeoplasm StagingPeripheral Nervous System DiseasesAntibodies, Monoclonal, HumanizedFluorodeoxyuridylatePlatinumNeutropeniaInfusions, Intra-ArterialNeoadjuvant TherapyDrug SynergismMitomycinCyclophosphamideThiophenesAntimetabolitesPancreatic NeoplasmsCell Line, TumorHCT116 CellsSemustineDoxorubicinTaxoidsEsophageal NeoplasmsHepatic ArteryOxonic AcidPeritoneal NeoplasmsHT29 CellsNauseaSalvage TherapyLevamisoleParesthesiaPaclitaxelLeukopeniaBreast NeoplasmsEsophagogastric JunctionDNA AdductsDisease ProgressionDiarrheaNeoplasm Recurrence, LocalAdministration, OralInjections, IntravenousKaplan-Meier EstimateHyperthermia, InducedTime FactorsStomatitisCarcinomaQuinazolinesLevoleucovorinNeoplasmsCarcinoma, Squamous CellBromouracilDrug HypersensitivityAntidotesFlucytosineDrug Screening Assays, AntitumorBiliary Tract NeoplasmsChemotherapy, Cancer, Regional PerfusionAntibodies, MonoclonalGastrointestinal NeoplasmsRadiotherapy, AdjuvantProdrugsHead and Neck NeoplasmsApoptosisPrognosisChemoradiotherapyPhosphoribosyl PyrophosphateCell Survival